Information Library

Results for: Cost control/reduction - Market Access

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Consulting – Breakthrough Thinking Built on Experience

    Brochure — November 23, 2010
    Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today.

  • New York State's New PACeR Clinical Data Network

    White Paper — August 5, 2010
    This briefing describes how the PACeR initiative has connected hospitals, physicians, patients' homes and pharmaceutical scientists to provide valuable insights into current, real-world medical practices.

  • A Blueprint for Clinical / Commercial Convergence

    White Paper — August 5, 2010
    The development model for bio pharmaceutical companies must shift from two divergent paths to one that combines these two resources with market access strategy, information and capabilities.

  • QUINTILES AND MOVETIS ANNOUNCE STRATEGIC ALLIANCE

    Press Release — January 28, 2010 - Quintiles announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany.

  • Matthew Eberhart

    Hear from the Experts — March 25, 2009
    Matt is a proven business-building executive with a strong track record of implementing successful business development initiatives for consulting healthcare companies in both North America and Europe.

Page 1 of 1 (5 results)

Subscribe to Email Based on Your Interests

Set preferences